🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A study to evaluate the tolerability and acceptability of an investigationa...
Status
Completed
Location
Multiple Locations
Start Date
2014-12
Trial ID
NCT02455050
Treatments Being Tested
This research aimed to compare the effectiveness of a lipid-based artificia...
Status
Active Not Recruiting
Location
Mughal eye Hospital Johar town
Start Date
2025-03-20
Trial ID
NCT06913387
Treatments Being Tested
This study will evaluate the safety, efficacy, and acceptability of two art...
Status
Completed
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT01010282
This study will evaluate the safety and efficacy of a carboxymethylcellulos...
Status
Completed
Location
Multiple Locations
Start Date
2013-01
Trial ID
NCT01664949
Blockade of vascular endothelial growth factor (VEGF) with bevacizumab has ...
Status
Completed
Location
Institute of Ophthalmology, Conde de Valenciana Foundation
Start Date
2012-03
Trial ID
NCT02007174
Treatments Being Tested
The safety and tolerability of two new artificial tears will be compared to...
Status
Completed
Location
Multiple Locations
Start Date
2009-08
Trial ID
NCT00932477
The efficacy, safety and acceptability of a new artificial tear in subjects...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00514852
Treatments Being Tested
This study will evaluate the safety, efficacy, and acceptability of an eye ...
Status
Completed
Location
Multiple Locations
Start Date
2011-10-01
Trial ID
NCT01459588
This study will evaluate the safety and efficacy of a new artificial tear f...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00544713
Treatments Being Tested
This study will evaluate the safety and efficacy of cyclosporine 0.05% opht...
Status
Completed
Location
Multiple Locations
Start Date
2014-04-03
Trial ID
NCT02121847
Treatments Being Tested